Maternal serum screening for Down's syndrome in the first trimester of pregnancy (original) (raw)

BJOG: An International Journal of Obstetrics and Gynaecology, 1996

Maternal serum screening for Down's syndrome in early pregnancy

BMJ, 1988

Maternal serum markers in screening for Down syndrome

Ann Tabor

Clinical Genetics, 2008

α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome

John Owen

American Journal of Obstetrics and Gynecology, 1997

Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha- fetoprotein and unconjugated oestriol

Bernadette Mermillod

Human Reproduction, 1998

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study

Isabelle Czerkiewicz

American Journal of Obstetrics and Gynecology, 2013

A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol

Gail Prins

American Journal of Obstetrics and Gynecology, 1993

Maternal serum screening for Down's syndrome on population basis

Ulf-Håkan Stenman

Acta Obstetricia et Gynecologica Scandinavica, 1997

First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free β-hCG and pregnancy-associated plasma protein-A assays

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005

Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome

Nan Okun

Prenatal Diagnosis, 2010

Repeat maternal serum testing in multiple marker down's syndrome screening programmes

Prenatal Diagnosis, 1994

Down’s Syndrome Screening in the First Trimester with Additional Serum Markers: Indian Parameters

sujatha jagadeesh

The Journal of Obstetrics and Gynecology of India

Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight

BJOG: An International Journal of Obstetrics and Gynaecology, 1992

Down syndrome screening marker levels in women with a previous aneuploidy pregnancy

Prenatal Diagnosis, 2005

Strategies for antenatal detection of Down's syndrome

Jonathan Wyllie

Archives of Disease in Childhood - Fetal and Neonatal Edition, 1997

The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome

John Owen

American Journal of Obstetrics and Gynecology, 1994

Second Trimester Antenatal Screening for Down’s Syndrome

Guido Vranken

Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland

A. Perheentupa, Markku Ryynänen

European Journal of Human Genetics, 2001

The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2003

Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories

Peter Benn

Clinical chemistry, 2006

A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome

Françoise Muller

Prenatal Diagnosis, 1990

Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening

Geralyn Messerlian

Journal of Medical Screening, 2012

Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome

BJOG: An International Journal of Obstetrics and Gynaecology, 1988

Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing

Peter Benn

Clinica Chimica Acta, 2002

The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy

Michael Pugia

BMC Pregnancy and Childbirth, 2014

Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome

BJOG: An International Journal of Obstetrics and Gynaecology, 1989

Risk prediction for Down?s syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis

Hsiao-lin Hwa

Journal of Evaluation in Clinical Practice, 2007

Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution

British Medical Journal (Clinical research ed.), 1985

Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women

Karin Sundberg

Ultrasound in Obstetrics and Gynecology, 2005

Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region

David Howe

BMJ, 2002

The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system

Annals of Clinical Biochemistry, 2003

Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access(R) platform: suitability for use in first trimester Down's syndrome screening

Geralyn Messerlian

Journal of Medical Screening, 2010

Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy

Tri Nguyen

Clinica Chimica Acta, 1996

eta-analysis of first trimester Down syndrome screening tudies: free -human chorionic gonadotropin significantly utperforms intact human chorionic gonadotropin in a ultimarker protocol

Robert Galen

2007